We are seeking partners for our cytokine programs who have deep expertise in cancer immunotherapy and a track record of productively leveraging external innovation.  We expect to partner these programs in early clinical development but are open to discussions at any time with the right partner. We are also seeking collaborations in areas outside our portfolio focus, such as autoimmunity, metabolic disorders, and pain management where the partner brings deep expertise in a specific field and can help guide the choice of sensor and therapeutic.